Should public reporting be made for performance indicators on healthcare-associated infections?

Medecine et Maladies Infectieuses

Volumn 43, Issue 3, 2013, Pages 108-113

  Lucet, J C ^a,b   Parneix, P ^c   Grandbastien, B ^d   Berthelot, P ^e  

^a BICHAT HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL PELLEGRIN   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Healthcare associated infection; Indicator; Nosocomial infection; Public reporting; Quality improvement

Indexed keywords

HEALTH CARE FACILITY; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH INSURANCE; HIGH RISK PATIENT; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; MANDATORY REPORTING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PERFORMANCE MEASUREMENT SYSTEM; PUBLIC HEALTH; REVIEW; TOTAL QUALITY MANAGEMENT;

ACCESS TO INFORMATION; CROSS INFECTION; FRANCE; HUMANS; INFORMATION DISSEMINATION; POPULATION SURVEILLANCE; QUALITY ASSURANCE, HEALTH CARE; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RISK MANAGEMENT; SOCIETIES, SCIENTIFIC; TASK PERFORMANCE AND ANALYSIS; UNITED STATES;

EID: 84876813672     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2013.03.002     Document Type: Review

References (38)

1. Parneix P. La surveillance des infections nosocomiales en France: un élément clé des programmes nationaux. Bull Epid Hebdo 2011, 184-187. [http://www.invs.sante.fr/pmb/invs/(id)/PMB_9456 ed].
2. Thiolet J., Poujol I., Vaux S., Alleaume S., Coignard B. Le signalement des infections nosocomiales: un outil pour la détection et le suivi des infections émergentes en établissements de santé en France. Bull Epid Hebdo 2011, 192-197. [http://www.invs.sante.fr/pmb/invs/(id)/PMB_9459 ed].
3. Edmond M.B., Bearman G.M. Mandatory public reporting in the USA: an example to follow?. J Hosp Infect 2007, 65(Suppl. 2):182-188.
4. Institut de Veille Sanitaire. Recommandations pour la mise en oeuvre d'un tableau de bord de la lutte contre les infections nosocomiales au niveau de chaque établissement de santé français. Available at: Accessed 7 décembre 2012. http://www.sante.gouv.fr/IMG/pdf/rapport_INVS.pdf.
5. Donabedian A. Continuity and change in the quest for quality. Clin Perform Qual Health Care 1993, 1(1):9-16.
6. Haley R.W., Culver D.H., White J.W., et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985, 121(2):182-205.
7. McKibben L., Horan T.C., Tokars J.I., et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 2005, 26(6):580-587.
8. Tokars J.I., Richards C., Andrus M., et al. The changing face of surveillance for health care-associated infections. Clin Infect Dis 2004, 39(9):1347-1352.
9. Schneider E.C., Epstein A.M. Influence of cardiac surgery performance reports on referral practices and access to care. A survey of cardiovascular specialists. N Engl J Med 1996, 335(4):251-256.
10. Werner R.M., Asch D.A. The unintended consequences of publicly reporting quality information. JAMA 2005, 293(10):1239-1244.
11. Fung C.H., Lim Y.W., Mattke S., Damberg C., Shekelle P.G. Systematic review: the evidence that publishing patient care performance data improves quality of care. Ann Intern Med 2008, 148(2):111-123.
12. Hibbard J.H. What can we say about the impact of public reporting? Inconsistent execution yields variable results. Ann Intern Med 2008, 148(2):160-161.
13. Haustein T., Gastmeier P., Holmes A., et al. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis 2011, 11(6):471-481.
14. Weinstein R.A., Siegel J.D., Brennan P.J. Infection control report cards - securing patient safety. N Engl J Med 2005, 353(3):225-227.
15. Lin M.Y., Hota B., Khan Y.M., et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010, 304(18):2035-2041.
16. Mayer J., Greene T., Howell J., et al. Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis 2012, 55(3):364-370.
17. Klompas M., Platt R. Ventilator-associated pneumonia - the wrong quality measure for benchmarking. Ann Intern Med 2007, 147(11):803-805.
18. Meddings J.A., Reichert H., Rogers M.A., Saint S., Stephansky J., McMahon L.F. Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med 2012, 157(5):305-312.
19. Morgan D.J., Meddings J., Saint S., et al. Does nonpayment for hospital-acquired catheter-associated urinary tract infections lead to overtesting and increased antimicrobial prescribing?. Clin Infect Dis 2012, 55(7):923-929.
20. Emori T.G., Edwards J.R., Culver D.H., et al. Accuracy of reporting nosocomial infections in intensive care unit patients to the National Nosocomial Infections Surveillance System: a pilot study. Infect Control Hosp Epidemiol 1998, 19(5):308-316.
21. Zuschneid I., Geffers C., Sohr D., et al. Validation of surveillance in the intensive care unit component of the German nosocomial infections surveillance system. Infect Control Hosp Epidemiol 2007, 28(4):496-499.
22. Graves N., McGowan J.E. Nosocomial infection, the Deficit Reduction Act, and incentives for hospitals. JAMA 2008, 300(13):1577-1579.
23. Hayashi Y., Morisawa K., Klompas M., et al. Towards improved surveillance: the impact of ventilator-associated complications (VAC) on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013, 56:471-477.
24. Pearson A., Chronias A., Murray M. Voluntary and mandatory surveillance for methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) bacteraemia in England. J Antimicrob Chemother 2009, 64(Suppl. 1):i11-i17.
25. Wilson A.P., Kiernan M. Recommendations for surveillance priorities for healthcare-associated infections and criteria for their conduct. J Antimicrob Chemother 2012, 67(Suppl. 1):i23-i28.
26. Gastmeier P., Sohr D., Schwab F., et al. Ten years of KISS: the most important requirements for success. J Hosp Infect 2008, 70(Suppl. 1):11-16.
27. Tavolacci M., Merle V., Germain J., Czernichow P. Perception de l'indice composite des activités de lutte contre les infections nosocomiales par les patients et les professionnels de santé: enquête en Haute-Normandie. Bull Epid hebdo 2005, 12-13:104-107.
28. L'Heriteau F., Alberti C., Cohen Y., Troche G., Moine P., Timsit J.F. Nosocomial infection and multidrug-resistant bacteria surveillance in intensive care units: a survey in France. Infect Control Hosp Epidemiol 2005, 26(1):13-20.
29. Marshall M.N., Romano P.S., Davies H.T. How do we maximize the impact of the public reporting of quality of care?. Int J Qual Health Care 2004, 16(Suppl. 1):i57-i63.
30. Klompas M. Eight initiatives that misleadingly lower ventilator-associated pneumonia rates. Am J Infect Control 2012, 40(5):408-410.
31. Pronovost P.J., Goeschel C.A., Wachter R.M. The wisdom and justice of not paying for "preventable complications". JAMA 2008, 299(18):2197-2199.
32. Edmond M.B. Getting to zero: is it safe?. Infect Control Hosp Epidemiol 2009, 30(1):74-76.
33. Carlet J., Fabry J., Amalberti R., Degos L. The "zero risk" concept for hospital-acquired infections: a risky business!. Clin Infect Dis 2009, 49(5):747-749.
34. Klompas M., Kleinman K., Khan Y., et al. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis 2012, 54(3):370-377.
35. Danet S., Regnier B. Infections du site opératoire: limites de la surveillance pour des comparaisons entre services et établissements de santé. Bull Epid Hebdo 2007, 12-13:95-102. ANAES Gdt.
36. Lee G.M., Kleinman K., Soumerai S.B., et al. Effect of nonpayment for preventable infections in U.S. hospitals. N Engl J Med 2012, 367(15):1428-1437.
37. Haut Conseil de la santé publique, Société française d'hygiène hospitalière. Surveiller et prévenir les infections associées aux soins. Available at: Accessed 7 décembre 2012. http://www.sf2h.net/publications-SF2H/SF2H_surveiller-et-prevenir-les-IAS-2010.pdf.
38. Stricof R.L., Van Antwerpen C., Smith P.F., Birkhead G.S. Lessons learned while implementing mandatory health care-associated infection reporting in New York State. J Public Health Manag Pract 2012, [Epub ahead of print].